쿼드메디슨 Stock: price and insider trades · South Korea
1 insider bought €32k of shares over the last 90 days, the latest by 백승기, filed 31 Aug 2026.
쿼드메디슨: what insiders have been doing
This page follows insider dealings at 쿼드메디슨 as filed with DART (FSS), a company from the Health Care sector. The last twelve months, up to 2 November 2026, brought 21 filings signed by 12 insiders.
Both sides are active: 19 purchases and 2 sales, from 12 insiders and 2 insiders respectively. No amount is published for 21 filings, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The buyers include 9 board members, 1 senior executive and 1 chief executive.
The most recent open-market purchase was published on 31 August 2026, 70 days ago. The median gap between a trade and its publication by DART (FSS) is 4 days. That lag is the time during which only the insider knows about the trade.
With 21 filings in twelve months, the company is more active than the median of 7 filings across the 2,655 companies we follow on the same exchange. Our records for 쿼드메디슨 go back to 2025, with 19 purchases and 2 sales on the open market in total.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and UCB. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Who traded when
BuySale+6 other insiders
Since the insiders bought
- -71.0%Entry ₩14,330 · Close 30 Oct 2026 ₩4,150
- -71.0%Entry ₩14,330 · Close 30 Oct 2026 ₩4,150
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Financial data
· cache
- Other0DART
- Other0DART
- Other0DART
- 10,000 sharesShareKRXDART:20260831001478Canonical exit: 29 Nov 2026 (T+90)
- Other0DART
- 15,370 sharesShareKRXDART:20260722000301Canonical exit: 20 Oct 2026 (T+90)
- 25,149 sharesShareKRXDART:20260615000089Canonical exit: 13 Sept 2026 (T+90)
- 10,000 sharesShareKRXDART:20260424000257Canonical exit: 22 Jul 2026 (T+90)
- 4,040 sharesShareKRXDART:20260424000255Canonical exit: 22 Jul 2026 (T+90)
- 118,510 sharesKRXDART:20260206000873
- Other0DART
- Other0DART
- 10,000 sharesShareKRXDART:20260206000742Canonical exit: 7 May 2026 (T+90)
- 19,320 sharesKRXDART:20260107000745Canonical exit: 1 Apr 2026 (T+90)
- 5,880 sharesShareKRXDART:20260107000743
- 25,200 sharesShareKRXDART:20260107000735Canonical exit: 7 Apr 2026 (T+90)
- 764,400 sharesKRXDART:20251219000488Canonical exit: 12 Mar 2026 (T+90)
- 80,300 sharesShareKRXDART:20251217000601Canonical exit: 18 Mar 2026 (T+90)
- 20,000 sharesShareKRXDART:20251217000385Canonical exit: 17 Mar 2026 (T+90)
- 52,500 sharesShareKRXDART:20251217000379Canonical exit: 17 Mar 2026 (T+90)
- 5,880 sharesShareKRXDART:20251217000387Canonical exit: 17 Mar 2026 (T+90)
- 63,000 sharesShareKRXDART:20251217000375Canonical exit: 17 Mar 2026 (T+90)
- 48,300 sharesShareKRXDART:20251217000384Canonical exit: 17 Mar 2026 (T+90)
- 2,988,430 sharesKRXDART:20251217000368Canonical exit: 12 Mar 2026 (T+90)
- 441,000 sharesShareKRXDART:20251217000372Canonical exit: 17 Mar 2026 (T+90)
25 of 27 declarations
About 쿼드메디슨
Quad Medicine is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions to enhance healthcare.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
